VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2016 | FAST: a Phase III trial of an anti-CLDN18.2 antibody GEJ adenocarcinoma

Salah-Eddin Al-Batran • 3 Jun 2016
ASCO 2016
Gastrointestinal Cancer
FAST

Press brief by Salah-Eddin Al-Batran, MD of the Krankenhaus Nordwest-University Cancer Center, Frankfurt, Germany, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.

Related Videos

3:41
Highlights in gastric cancer from ESMO 2021
Yelena Y. Janjigian • 28 Sep 2021
3:01
Genomic landscape of late-stage gastric cancer treated with pembrolizumab
Yelena Y. Janjigian • 28 Sep 2021
1:54
Updates in treatments for HER2-positive GEA
Geoffrey Ku • 27 Sep 2021
1:58
DESTINY-Gastric02: T-Dxd as a second-line treatment for HER2-positive gastric cancer
Elizabeth Smyth • 21 Sep 2021
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals